77 related articles for article (PubMed ID: 21319993)
1. Identification of novel prognostic markers in relapsing localized resectable neuroblastoma.
Parodi F; Passoni L; Massimo L; Luksch R; Gambini C; Rossi E; Zuffardi O; Pistoia V; Pezzolo A
OMICS; 2011 Mar; 15(3):113-21. PubMed ID: 21319993
[TBL] [Abstract][Full Text] [Related]
2. Presence of 1q gain and absence of 7p gain are new predictors of local or metastatic relapse in localized resectable neuroblastoma.
Pezzolo A; Rossi E; Gimelli S; Parodi F; Negri F; Conte M; Pistorio A; Sementa A; Pistoia V; Zuffardi O; Gambini C
Neuro Oncol; 2009 Apr; 11(2):192-200. PubMed ID: 18923191
[TBL] [Abstract][Full Text] [Related]
3. Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma.
Spitz R; Hero B; Simon T; Berthold F
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3368-73. PubMed ID: 16740759
[TBL] [Abstract][Full Text] [Related]
4. Neuroblastoma in adolescents: the Italian experience.
Conte M; Parodi S; De Bernardi B; Milanaccio C; Mazzocco K; Angelini P; Viscardi E; Di Cataldo A; Luksch R; Haupt R
Cancer; 2006 Mar; 106(6):1409-17. PubMed ID: 16475209
[TBL] [Abstract][Full Text] [Related]
5. Localized pelvic neuroblastoma: excellent survival and low morbidity with tailored therapy--the 10-year experience of the French Society of Pediatric Oncology.
Leclair MD; Hartmann O; Heloury Y; Fourcade L; Laprie A; Mechinaud F; Munzer C; Rubie H
J Clin Oncol; 2004 May; 22(9):1689-95. PubMed ID: 15117991
[TBL] [Abstract][Full Text] [Related]
6. Overall genomic pattern is a predictor of outcome in neuroblastoma.
Janoueix-Lerosey I; Schleiermacher G; Michels E; Mosseri V; Ribeiro A; Lequin D; Vermeulen J; Couturier J; Peuchmaur M; Valent A; Plantaz D; Rubie H; Valteau-Couanet D; Thomas C; Combaret V; Rousseau R; Eggert A; Michon J; Speleman F; Delattre O
J Clin Oncol; 2009 Mar; 27(7):1026-33. PubMed ID: 19171713
[TBL] [Abstract][Full Text] [Related]
7. Evolving significance of prognostic markers associated with new treatment strategies in neuroblastoma.
Mora J; Gerald WL; Cheung NK
Cancer Lett; 2003 Jul; 197(1-2):119-24. PubMed ID: 12880970
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization.
Scaruffi P; Coco S; Cifuentes F; Albino D; Nair M; Defferrari R; Mazzocco K; Tonini GP
Cancer Genet Cytogenet; 2007 Aug; 177(1):20-9. PubMed ID: 17693187
[TBL] [Abstract][Full Text] [Related]
9. Increased WSB1 copy number correlates with its over-expression which associates with increased survival in neuroblastoma.
Chen QR; Bilke S; Wei JS; Greer BT; Steinberg SM; Westermann F; Schwab M; Khan J
Genes Chromosomes Cancer; 2006 Sep; 45(9):856-62. PubMed ID: 16804916
[TBL] [Abstract][Full Text] [Related]
10. Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma.
Spitz R; Hero B; Ernestus K; Berthold F
Clin Cancer Res; 2003 Jan; 9(1):52-8. PubMed ID: 12538451
[TBL] [Abstract][Full Text] [Related]
11. Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma group.
Mazzocco K; Defferrari R; Sementa AR; Garaventa A; Longo L; De Mariano M; Esposito MR; Negri F; Ircolò D; Viscardi E; Luksch R; D'Angelo P; Prete A; Castellano A; Massirio P; Erminio G; Gigliotti AR; Tonini GP; Conte M
Pediatr Blood Cancer; 2015 Oct; 62(10):1725-32. PubMed ID: 25925003
[TBL] [Abstract][Full Text] [Related]
12. Chromosome 17/17q gain and unaltered profiles in high resolution array-CGH are prognostically informative in neuroblastoma.
Theissen J; Oberthuer A; Hombach A; Volland R; Hertwig F; Fischer M; Spitz R; Zapatka M; Brors B; Ortmann M; Simon T; Hero B; Berthold F
Genes Chromosomes Cancer; 2014 Aug; 53(8):639-49. PubMed ID: 24737690
[TBL] [Abstract][Full Text] [Related]
13. Gene-expression-based analysis of local and metastatic neuroblastoma variants reveals a set of genes associated with tumor progression in neuroblastoma patients.
Nevo I; Oberthuer A; Botzer E; Sagi-Assif O; Maman S; Pasmanik-Chor M; Kariv N; Fischer M; Yron I; Witz IP
Int J Cancer; 2010 Apr; 126(7):1570-81. PubMed ID: 19739072
[TBL] [Abstract][Full Text] [Related]
14. Genomic Analysis Made It Possible to Identify Gene-Driver Alterations Covering the Time Window between Diagnosis of Neuroblastoma 4S and the Progression to Stage 4.
Ognibene M; De Marco P; Parodi S; Meli M; Di Cataldo A; Zara F; Pezzolo A
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742955
[TBL] [Abstract][Full Text] [Related]
15. Distillation of the clinical algorithm improves prognosis by multi-task deep learning in high-risk Neuroblastoma.
Maggio V; Chierici M; Jurman G; Furlanello C
PLoS One; 2018; 13(12):e0208924. PubMed ID: 30532223
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of International Neuroblastoma Pathology Classification in localized resectable peripheral neuroblastic tumors: a histopathologic study of localized neuroblastoma European Study Group 94.01 Trial and Protocol.
Navarro S; Amann G; Beiske K; Cullinane CJ; d'Amore ES; Gambini C; Mosseri V; De Bernardi B; Michon J; Peuchmaur M;
J Clin Oncol; 2006 Feb; 24(4):695-9. PubMed ID: 16446343
[TBL] [Abstract][Full Text] [Related]
17. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H
Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780
[TBL] [Abstract][Full Text] [Related]
18. Two cases of localized neuroblastoma with multiple segmental chromosomal alterations and metastatic progression.
Morales La Madrid A; Nall MB; Ouyang K; Minor A; Raca G; Kent P; Miller I; Schleiermacher G; Janoueix-Lerosey I; Cohn SL
Pediatr Blood Cancer; 2013 Feb; 60(2):332-5. PubMed ID: 22997192
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of TrkA protein detection by monoclonal antibody 5C3 in neuroblastoma.
Kramer K; Gerald W; LeSauteur L; Uri Saragovi H; Cheung NK
Clin Cancer Res; 1996 Aug; 2(8):1361-7. PubMed ID: 9816308
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of segmental alterations determines progression in neuroblastoma.
Schleiermacher G; Janoueix-Lerosey I; Ribeiro A; Klijanienko J; Couturier J; Pierron G; Mosseri V; Valent A; Auger N; Plantaz D; Rubie H; Valteau-Couanet D; Bourdeaut F; Combaret V; Bergeron C; Michon J; Delattre O
J Clin Oncol; 2010 Jul; 28(19):3122-30. PubMed ID: 20516441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
